If you have a medical condition that requires Use of a substance or a method that is on the Prohibited List, a Therapeutic Use Exemption (TUE) is required. A TUE permits you to use the prohibited medication or method without committing an Anti-Doping Rule Violation, providing that all such use is in accordance with the conditions of the TUE.
If you are unsure if a product contains a Prohibited Substance or whether you require a TUE, complete a Product Information Request form on the Tennis Anti-Doping app (available to download on Android and Apple devices).
All applications for a TUE must be made through the online TUE Portal. For further information on the application process, read the related PDF in link below, and the FAQ section.
TUEs are required for events covered by the Tennis Anti-Doping Programme: the Grand Slam tournaments, Davis Cup, Fed Cup, Hopman Cup, the Olympic Tennis event, the Paralympic Tennis event, other IOC-recognised International Events, WTA tournaments and WTA Finals and WTA Elite Trophy, ATP Tour tournaments and ATP Finals, Next Gen ATP Finals, ATP Challenger Tour tournaments, ITF Pro Circuit events, ITF World Tennis Tour events, ITF Juniors events, ITF Seniors events, ITF Wheelchair events, and ITF Beach Tennis Tour events.
For players who have had a TUE granted by their National Anti-Doping Agency, an application must be made for Mutual Recognition through the TUE Portal, 30 days prior to participating in a covered event. The conditions of any TUE granted by a NADO may be amended prior to being recognised under the Tennis Anti-Doping Programme. For further information, see the ‘Mutual Recognition’ section.
Retroactive TUEs may only be granted in exceptional circumstances where there was insufficient time or opportunity for an applicant to submit, or a TUE Committee to consider, an application prior to Doping Control. For further information, read the related PDF in link below.
Use of a prohibited substance without a valid TUE is at the players’ own risk.